BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19254647)

  • 1. [Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us].
    Bellido-Blasco JB; Arnedo-Pena A; Romeo-García MA; Herrero-Carot C
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):136-7. PubMed ID: 19254647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Canine leishmaniasis in Spain: data for the clinician].
    Ferrer L
    Enferm Infecc Microbiol Clin; 1989; 7(6):293-5. PubMed ID: 2490443
    [No Abstract]   [Full Text] [Related]  

  • 3. Some remarks about the LeishVet directions for the treatment of canine leishmaniasis.
    Lamothe J
    Vet Parasitol; 2010 May; 169(3-4):416-7; author reply 418-20. PubMed ID: 20106598
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis.
    Pennisi MG; Lo Giudice S; Masucci M; De Majo M; Reale S; Vitale F
    Vet Res Commun; 2008 Sep; 32 Suppl 1():S303-5. PubMed ID: 18683068
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.
    Aste G; Di Tommaso M; Steiner JM; Williams DA; Boari A
    Vet Res Commun; 2005 Aug; 29 Suppl 2():269-72. PubMed ID: 16244972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Meeting "Visceral leishmaniasis in Maghreb", 2-4 April 2015 in Tunis. Recommendations].
    Aoun K; Laamrani El Idrissi A; Harrat Z; Marty P
    Bull Soc Pathol Exot; 2015 Aug; 108(3):229-30. PubMed ID: 26002086
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
    Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog.
    Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E
    J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
    Font A; Gines C; Closa JM; Mascort J
    J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.
    Travi BL; Cordeiro-da-Silva A; Dantas-Torres F; Miró G
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006082. PubMed ID: 29324838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of meglumine antimoniate in canine leishmaniasis.
    Lamothe J
    Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-epidemiological study of kala-azar in the south of Madrid].
    de la Serna FJ; Salto E; Valdés D; Vos Saus R
    Rev Sanid Hig Publica (Madr); 1987; 61(7-8):783-98. PubMed ID: 3438697
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy.
    Gradoni L; Gramiccia M; Mancianti F; Pieri S
    Trans R Soc Trop Med Hyg; 1988; 82(4):568-71. PubMed ID: 3256109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Ciarlini PC; Marques FJ; Lima VM; Perri SH; Feitosa MM
    Res Vet Sci; 2007 Aug; 83(1):105-8. PubMed ID: 17150234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Am J Dis Child; 1992 Sep; 146(9):1021. PubMed ID: 1514542
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous leishmaniasis in French Guiana: a review.
    Dedet JP
    Am J Trop Med Hyg; 1990 Jul; 43(1):25-8. PubMed ID: 2200289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015.
    Wkly Epidemiol Rec; 2017 Sep; 92(35):566-72. PubMed ID: 28945058
    [No Abstract]   [Full Text] [Related]  

  • 19. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
    João A; Pereira MA; Cortes S; Santos-Gomes GM
    J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parasitological and immunological progress control during and after chemotherapy of canine leishmaniasis].
    Deplazes P; Arnold P; Skaggs J; Gessler M
    Schweiz Arch Tierheilkd; 1992; 134(2):85-93. PubMed ID: 1566026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.